EUR 9.1
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | - EUR | 0.0% |
2022 | - EUR | 0.0% |
2021 | - EUR | -100.0% |
2020 | 41 Million EUR | 17.48% |
2019 | 34.9 Million EUR | -8.16% |
2018 | 38 Million EUR | -9.31% |
2017 | 41.9 Million EUR | -0.48% |
2016 | 42.1 Million EUR | 83.84% |
2015 | 22.9 Million EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | - EUR | 0.0% |
2024 Q2 | - EUR | 0.0% |
2023 Q2 | - EUR | 0.0% |
2023 Q1 | - EUR | 0.0% |
2023 Q4 | - EUR | 0.0% |
2023 Q3 | - EUR | 0.0% |
2023 FY | - EUR | 0.0% |
2022 Q1 | - EUR | 0.0% |
2022 Q2 | - EUR | 0.0% |
2022 Q3 | - EUR | 0.0% |
2022 Q4 | - EUR | 0.0% |
2022 FY | - EUR | 0.0% |
2021 Q2 | - EUR | 0.0% |
2021 FY | - EUR | -100.0% |
2021 Q1 | - EUR | 0.0% |
2020 Q1 | - EUR | -100.0% |
2020 FY | 41 Million EUR | 17.48% |
2020 Q4 | - EUR | 0.0% |
2020 Q2 | - EUR | 0.0% |
2020 Q3 | - EUR | 0.0% |
2019 Q1 | 9650.00 EUR | 24.52% |
2019 Q4 | 7800.00 EUR | 0.0% |
2019 Q2 | 9650.00 EUR | 0.0% |
2019 FY | 34.9 Million EUR | -8.16% |
2019 Q3 | 7800.00 EUR | -19.17% |
2018 Q2 | 11.25 Thousand EUR | 0.0% |
2018 Q3 | 7750.00 EUR | -31.11% |
2018 Q4 | 7750.00 EUR | 0.0% |
2018 FY | 38 Million EUR | -9.31% |
2018 Q1 | 11.25 Thousand EUR | 10.84% |
2017 FY | 41.9 Million EUR | -0.48% |
2017 Q4 | 10.15 Thousand EUR | 0.0% |
2017 Q3 | 10.15 Thousand EUR | -6.02% |
2017 Q2 | 10.8 Thousand EUR | 0.0% |
2017 Q1 | 10.8 Thousand EUR | 10.2% |
2016 Q1 | 11.25 Thousand EUR | -99.89% |
2016 FY | 42.1 Million EUR | 83.84% |
2016 Q4 | 9800.00 EUR | 0.0% |
2016 Q3 | 9800.00 EUR | -12.89% |
2016 Q2 | 11.25 Thousand EUR | 0.0% |
2015 FY | 22.9 Million EUR | 0.0% |
2015 Q2 | 5.72 Million EUR | 0.0% |
2015 Q1 | 5.72 Million EUR | 0.0% |
2015 Q4 | 10.52 Million EUR | 83.84% |
2015 Q3 | 5.72 Million EUR | 0.0% |
2014 Q4 | 5.72 Million EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
AB Science S.A. | 970 Thousand EUR | 100.0% |
Boiron SA | 493.24 Million EUR | 100.0% |
Ipsen S.A. | 3.3 Billion EUR | 100.0% |
Vetoquinol SA | 529.27 Million EUR | 100.0% |